Patient Engagement
Patients and patient groups are becoming more sophisticated about their role in the research system. How can policymakers, innovators, payers, and researchers take into account patient needs and preferences, patient-reported outcomes, and patients’ perceptions of risk and value in a meaningful way? Learn more here about models of effective patient engagement.
Featured Items
Tools you can use
Patients Count Network
Source: FasterCures
Visual Model of Patient Engagement in Benefit-Risk Assessment through the Medical Product Life Cycle
Source: DIA
The A to Z of how medicines are developed
Source: European Patients' Academy
Patient Group Organizational Expertise & Assets Evaluation Tool
Source: Clinical Trials Transformation Initiative
Advancing Meaningful Patient Engagement in Research, Development, and Review of Drugs
Source: Genetic Alliance and National Health Council
Assessing Meaningful Patient Engagement in Drug Development: A Definition, Framework, and Rubric
Source: University of Maryland's Center of Excellence in Regulatory Science and Innovation (M-CERSI)
Participant-centered consent toolkit
Source: Sage Bionetworks
Patient and family engagement rubric
Source: Patient-Centered Outcomes Research Institute
A Roadmap for Patient + Family Engagement in Healthcare
Source: American Institutes for Research
Meaningful Consumer Engagement: A Toolkit for Plans, Provider Groups and Communities
Source: Community Catalyst
Patient Group Engagement Across the Clinical Trial Continuum
Source: Clinical Trials Transformation Initiative
Patient perspective and disease impact stratification tool
Source: National Health Council
Clinical and Translational Sciences Awards Consortium Principles of Community Engagement
Source: NIH-National Center for Advancing Translational Sciences (NCATS)
Implementation manual: How to operationalize the National Health Council’s Patient Information Tool
Source: National Health Council
Publications & Events
Key Considerations for Developing & Integrating Patient Perspectives in Drug Development: Examination of the Duchenne Case Study
Source: BIO & PPMD
Integrating the Patient Perspective into the Development of Value Frameworks
Source: Avalere and FasterCures
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
Source: Orphanet Journal of Rare Diseases
Lifecycle Approach to FDA’s Structured Benefit-Risk Assessment
Source: Biotechnology Innovation Organization (BIO)
Financial Compensation for PCORI-Funded Research Partners
Source: Patient-Centered Outcomes Research Institute
Executive summary of the Patient Group and Clinical Trials Project Expert Meeting
Source: Clinical Trials Transformation Initiative